Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option

Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option

Abstract The treatment of metastatic melanoma patients with autologous tumor-infiltrating lymphocytes (TIL) shows robust, reproducible, clinical responses in clinical trials executed in several specialized centers over the world. Even in the era of targeted therapy and immune checkpoint inhibition,...

Full description

Bibliographic Details
Main Authors: Maartje W. Rohaan, Joost H. van den Berg, Pia Kvistborg, John B. A. G. Haanen
Format: Article
Language:English
Published: BMJ Publishing Group 2018-10-01
Series:Journal for ImmunoTherapy of Cancer
Subjects:
Melanoma
Adoptive cell therapy
Tumor-infiltrating lymphocytes
Immunotherapy
Lymphodepletion
Interleukin-2
Online Access:http://link.springer.com/article/10.1186/s40425-018-0391-1

Internet

http://link.springer.com/article/10.1186/s40425-018-0391-1

Similar Items